Atnaujinkite slapukų nuostatas

Carbohydrate-Based Therapeutics [Kietas viršelis]

Edited by (GSK, Italy), Edited by (University of Milan, Italy)
  • Formatas: Hardback, 416 pages, aukštis x plotis x storis: 244x170x27 mm, weight: 851 g
  • Išleidimo metai: 04-Oct-2023
  • Leidėjas: Blackwell Verlag GmbH
  • ISBN-10: 3527348700
  • ISBN-13: 9783527348701
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 416 pages, aukštis x plotis x storis: 244x170x27 mm, weight: 851 g
  • Išleidimo metai: 04-Oct-2023
  • Leidėjas: Blackwell Verlag GmbH
  • ISBN-10: 3527348700
  • ISBN-13: 9783527348701
Kitos knygos pagal šią temą:

Comprehensive resource summarizing opportunities and latest progress in design methodologies for carbohydrate-based therapeutics through a disease-oriented approach

Carbohydrate-Based Therapeutics covers current progress and explores new frontiers in carbohydrate-based therapeutic applications, utilizing a unique approach by providing a detailed background of diseases coupled with subsequent carbohydrate-based therapies. The link between chemistry and design of novel carbohydrate-based medicines is highlighted and a broad overview of all the potential applications of carbohydrates is given.

Emphasis is laid on concepts used for carbohydrate drug design, structure-activity relationship, and impact on health and diseases. The text also discusses newer topics like nanoparticles, material science, and tissue generation.

Carbohydrate-Based Therapeutics includes information on:

  • Antimicrobial carbohydrate-based therapies, covering antibacterial and antiviral vaccines, antifungal therapies, anti influenza therapeutics, and antiadhesive carbohydrates and glycomimetics
  • Anti-cancer carbohydrate-based therapies, covering cancer vaccines and immunotherapy, carbohydrate tools in cancer biology, and carbohydrates and glycoconjugates in autophagy
  • Carbohydrate-based therapies in metabolic, neuronal, and immune disorders, covering carbohydrate-based therapeutics for lysosomal disorders and neurodegenerative diseases
  • New frontiers in carbohydrate-based therapies, covering carbohydrates for tissue engineering, antiangiogenic and regenerative medicine, and bowel diseases

Providing comprehensive coverage of foundational knowledge on the subject in a unique and highly accessible format while also exploring the state of the art in the field’s applications, Carbohydrate-Based Therapeutics is an essential resource for medicinal, pharmaceutical, and organic chemists, chemists in industry, biochemists, and biotechnologists.

PART I
ANTIMICROBIAL CARBOHYDRATE BASED THERAPIES
Antibacterial Vaccines
Antiviral Vaccines
Antifungal Therapies
Anti Influenza Therapeutics
Antiadhesive Carbohydrates and Glycomimetics

PART II
ANTI CANCER CARBOHYDRATE-BASED THERAPIES

Cancer Vaccines and Immunotherapy
Carbohydrate Tools in Cancer Biology
Carbohydrates and Glycoconjugates in Autophagy
Lectin Ligands to Target Cancer

PART III
CARBOHYDRATE-BASED THERAPIES IN METABOLIC, NEURONAL AND IMMUNE DISORDERS
Carbohydrate-Based Therapeutics for Lysosomal Disorders
Carbohydrate-Based Therapeutics for Neurodegenerative Diseases
Carbohydrate-Based Antithrombotics
Glycans and Blood Types
Carbohydrate-Based Therapeutics for Autoimmune Diseases
N-Glycosylation of Antibodies and Immunity
Type 1 Diabetes

PART IV
NEW FRONTIERS IN CARBOHYDRATE-BASED THERAPIES
Carbohydrates for Tissue Engineering
Antiangiogenic and Regenerative Medicine
Carbohydrate-Based Therapeutics for Bowel Diseases
Roberto Adamo joined GSK (formerly Novartis Vaccines) in 2007 where he was later appointed as Head of the Carbohydrate Chemistry Laboratory, and Leader of the Conjugation & Synthesis Platform. He is currently Project Leader at GSK, Italy.

Luigi Lay is Full Professor at the Department of Chemistry of the University of Milan, Italy. His research focuses on carbohydrate chemistry and the use of synthetic glycans to investigate their biological properties.